Evaluation of Outcomes From Treatment of Benign or Malignant Pancreatic Diseases
NCT04055571 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2024-03-27
Summary
This study will be a retrospective chart review of patients who have been diagnosed with the benign or malignant pancreatic disease under the practice of Dr. Rohan Jeyarajah, M.D., Dr. Houssam Osman M.D., and Dr. Edward Cho M.D., Sc.M. at Methodist Health System Hospital in Richardson, TX. The investigators plan to conduct an analysis of patients meeting the inclusion criteria from 2005 to present. Study will also be conducted by the PI, Sub-Is, surgery fellows, office staff and clinical research coordinator who are delegated to do by the PI. Data will be obtained by looking through either investigator's patients or through a national database. Data will be analyzed primarily by the study conductors.
Conditions
- Benign or Malignant Pancreatic Diseases
Sponsors & Collaborators
-
Methodist Health System
lead OTHER
Principal Investigators
-
Dhiresh Jeyarajah, M.D. · Methodist Richardson Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-05
- Primary Completion
- 2025-01-30
- Completion
- 2025-01-30
Countries
- United States
Study Locations
More Related Trials
-
Trial to Improve Outcomes in Patients With Resected Pancreatic Cancer (Azacitidine)
NCT01845805 ·Status: COMPLETED ·Phase: PHASE2
-
Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx
NCT00767273 ·Status: COMPLETED ·Phase: NA
-
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
NCT00830557 ·Status: RECRUITING
-
Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer
NCT04975516 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer
NCT04257448 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase II Trial of CG 8020 and CG 2505 in Patients With Nonresectable or Metastatic Pancreatic Cancer
NCT00245362 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Pancreatic Endoscopic Drainage on Exocrine Pancreatic Function in Unresectable Pancreatic Cancer
NCT05244174 ·Status: UNKNOWN ·Phase: NA
-
Pilot Study of Pancreatic Cancer Screening
NCT05058846 ·Status: RECRUITING
-
Nab-Paclitaxel + Cisplatin + Gemcitabine in Untreated Metastatic Pancreatic Adenocarcinoma
NCT03915444 ·Status: COMPLETED ·Phase: PHASE2
-
Should a Standard Lymphadenectomy Include the No. 16 Lymph Nodes for Patients With Pancreatic Head Adenocarcinoma.
NCT04115527 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas
NCT04275557 ·Status: RECRUITING
-
The Development of a Metabolomic Test to Diagnose and Quantify Pancreatic Exocrine Insufficiency (The DETECTION Study)
NCT05980221 ·Status: UNKNOWN ·Phase: NA
-
Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of Pancreas
NCT00038701 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydrochloroquine as Treatment in Untreated Pancreas Cancer
NCT04669197 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer
NCT05356039 ·Status: RECRUITING
-
Frequency of Methods of Local Invasion of Pancreatic Adenocarcinoma
NCT01129167 ·Status: COMPLETED
-
Observational Study of Quality of Live in Patients With Metastatic Pancreatic Cancer
NCT02342847 ·Status: COMPLETED
-
Registry for Pancreatic Cancer
NCT03001505 ·Status: WITHDRAWN
-
Molecular Subtyping for Prognosis Evaluation in Resected Pancreatic Adenocarcinoma
NCT05483257 ·Status: COMPLETED
-
A Phase 1 Study of Safety and Bioactivity With FG-3019 in Combination With Gemcitabine and Erlotinib for Subjects With Locally Advanced or Metastatic Pancreatic Cancer
NCT01181245 ·Status: COMPLETED ·Phase: PHASE1
-
METabolic PROFILE of Hepatocarcinoma and Pancreatic Tumors
NCT05794048 ·Status: RECRUITING ·Phase: NA
-
Study of Single Agent Idelalisib Followed by Idelalisib in Combination With Chemotherapy in Adults With Metastatic Pancreatic Ductal Adenocarcinoma
NCT02468557 ·Status: TERMINATED ·Phase: PHASE1
-
Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
NCT01416662 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Three-dimensional Visualization on Operation Strategy and Complications for Pancreatic Cancer
NCT03749005 ·Status: UNKNOWN
-
Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis
NCT04858009 ·Status: RECRUITING ·Phase: PHASE2